{"id":"W3092162886","doi":"10.1186/s12931-020-01513-x","title":"CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma","year":2020,"lang":"en","type":"article","venue":"Respiratory Research","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca; Amgen","keywords":"Medicine; Thymic stromal lymphopoietin; Asthma; Placebo; Airway; Allergy; Clinical endpoint; Internal medicine; Immunology; Eosinophilic; Randomized controlled trial; Pathology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009549213,0.000459932,0.0021187,0.000732216,0.0002486694,0.00007511681,0.0004195297,0.0002302616,0.000182567],"category_scores_gemma":[0.004429925,0.0002330515,0.0004973926,0.001330638,0.0004203193,0.0001526901,0.0001281351,0.001029451,0.0001701058],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000227099,"about_ca_system_score_gemma":0.0006511028,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000028249,"about_ca_topic_score_gemma":0.00003119764,"domain_scores_codex":[0.9885172,0.005708998,0.001264108,0.0007395752,0.002997896,0.0007721892],"domain_scores_gemma":[0.994499,0.003209496,0.0002626883,0.0007287668,0.0006266682,0.0006734022],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9849123,0.0006793732,0.002022086,0.0001919369,0.0003521402,0.0000730238,0.0003437498,0.001012957,0.0007180127,0.00004724693,0.000462488,0.009184632],"study_design_scores_gemma":[0.9490229,0.04444419,0.0005107086,0.0002596869,0.000210025,6.281098e-7,0.00007912247,0.0008625392,0.002212219,0.000003261756,0.002174102,0.0002205656],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.966006,0.0003048476,0.00007037218,0.001227411,0.00007991915,0.03123122,0.00001502876,0.00004766893,0.001017565],"genre_scores_gemma":[0.9939154,0.00000541851,0.00001269498,0.0004795409,0.0006179929,0.004790923,0.00002267336,0.00006851069,0.00008686388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04376482,"threshold_uncertainty_score":0.9503565,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04846511786439189,"score_gpt":0.3771722020565846,"score_spread":0.3287070841921927,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}